![Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes | TechAlliance Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes | TechAlliance](http://techalliance.ca/wp-content/uploads/2020/02/sernova-feb-2020.png)
Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes | TechAlliance
dpa-AFX Compact | IRW-News: Sernova Corp. : Sernova gibt positive aktualisierte klinische Phase-1/2-Daten zum Cell Pouch System bei den 82. Wissenschaftlichen Sitzungen der American Diabetes Association bekannt
![Sernova: Perfekter Partner für Diabetes-Programm von Evotec? - shareribs.com - Technology - IT und Kommunikation Sernova: Perfekter Partner für Diabetes-Programm von Evotec? - shareribs.com - Technology - IT und Kommunikation](https://www.shareribs.com/uploads/RTEmagicC_20200602-PSH-RM-Diabetes-Competitive-Landscape.jpg.jpg)
Sernova: Perfekter Partner für Diabetes-Programm von Evotec? - shareribs.com - Technology - IT und Kommunikation
![Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram](https://www.researchgate.net/publication/309010262/figure/fig1/AS:416217190944778@1476245319903/Illustration-of-the-Sernova-Cell-Pouch-A-Plugs-in-situ-within-the-Cell-Pouch-B.png)
Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram
![IRW-News: Sernova Corp. : Sernovas Hauptprüfer präsentiert weitere positive, vorläufige Sicherheits- und Wirksamkeitsdaten aus der laufenden klinischen Phase-I/II-Studie zur Cell Pouch bei Typ-1-Diabetes in den USA IRW-News: Sernova Corp. : Sernovas Hauptprüfer präsentiert weitere positive, vorläufige Sicherheits- und Wirksamkeitsdaten aus der laufenden klinischen Phase-I/II-Studie zur Cell Pouch bei Typ-1-Diabetes in den USA](https://media.boersennews.de/images/news/diabetes-777002_1280.180.jpg)
IRW-News: Sernova Corp. : Sernovas Hauptprüfer präsentiert weitere positive, vorläufige Sicherheits- und Wirksamkeitsdaten aus der laufenden klinischen Phase-I/II-Studie zur Cell Pouch bei Typ-1-Diabetes in den USA
![Sernova - bahnbrechender Durchbruch bringt signifikantes Kurspotenzial, Global Biotech Network Ltd, Pressemitteilung - PresseBox Sernova - bahnbrechender Durchbruch bringt signifikantes Kurspotenzial, Global Biotech Network Ltd, Pressemitteilung - PresseBox](https://cdn.pressebox.de/a/eafacb0df4bdd7d2/attachments/1069909.attachment/filename/Sernova-Approach.jpeg)
Sernova - bahnbrechender Durchbruch bringt signifikantes Kurspotenzial, Global Biotech Network Ltd, Pressemitteilung - PresseBox
![Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant](https://bioinformant.com/wp-content/uploads/2023/01/first-ipsc-derived-islets-in-cell-pouch.png)
Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant
![Sernova: CEO-Exklusivinterview - Ver20facher für Ihr Depot - shareribs.com - Technology - IT und Kommunikation Sernova: CEO-Exklusivinterview - Ver20facher für Ihr Depot - shareribs.com - Technology - IT und Kommunikation](https://www.shareribs.com/uploads/RTEmagicC_20201130-PSH-Biologically-Compatible-Delivery-Process.jpg.jpg)
Sernova: CEO-Exklusivinterview - Ver20facher für Ihr Depot - shareribs.com - Technology - IT und Kommunikation
![Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I/II Cell Pouch Diabetes Clinical Trial | TechAlliance Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I/II Cell Pouch Diabetes Clinical Trial | TechAlliance](https://techalliance.ca/wp-content/uploads/2016/11/Sernova-Logo-png-big-300x161.png)
Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I/II Cell Pouch Diabetes Clinical Trial | TechAlliance
Sernova reported findings that further validate Cell Pouch™ and therapeutic cell performance in Type-1 diabetes | InvestmentPitch
![Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare](https://www.sernova.com/home/CellPouch.jpg)